About Us
About AJMC
About AJPB
About EBO
About EBD
Publications
AJMC
AJPB
Evidence-Based Diabetes Management
Evidence-Based Oncology
Supplements
Subscribe for FREE
AJMC TV
Interviews
Peer Exchange
Interactive
Interactive Tools
Featured Podcasts
Conferences
ACC 2013
AJMC Live Meeting - Oncology
AES2012
AHIP 2012
AHIP 2012 Fall Forum
AHIP Medicare Medicaid
AMCP Fall 2012
AMCP Spring 2013
ADA 2012
ADA 2013
ASH 2012
CHEST 2012
Joslin Diabetes Innovation
NAMCP 2012
NAMCP Spring 2013
SCAI 2013
ATS 2013
ASCO 2013
ASHP Summer 2013
Sleep 2013
News
Info for Authors
Information for Authors
Call for Papers
Submit / Track a Manuscript
Authorship Forms
Information for Reviewers
Resource Centers
Acute Coronary Syndrome
Biosimilars
Care Management
Diabetes
Evidence-Based Oncology
Pain
Value-Based Cardiology
Value-Based Insurance Design
Advertisement
Supplement
Archives
Issue:
Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty: Current and Future Perspectives
Volume:
17
Number:
1 Suppl
ARTICLES
Characteristics of Novel Anticoagulants and Potential Economic Implications
Edith Nutescu, PharmD, FCCP
New Oral Anticoagulants and Outpatient Prophylaxis of Venous Thromboembolism
William D. Fisher, MD
Quality Improvement Program: Advancement of Hospital Venous Thromboembolism - Free Zones
Geno Merli, MD, FACP, FHM, FSVM
Prevalence and Economic Burden of Venous Thromboembolism After Total Hip Arthroplasty or Total Knee Arthroplasty
Onur Baser, PhD
Cost-Effectiveness of Rivaroxaban After Total Hip or Total Knee Arthroplasty
Louis M. Kwong, MD, FACS
Epilogue
Geno Merli, MD, FACP, FHM, FSVM
AUTHOR INDEX
Participating Faculty: Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty
INTRODUCTION
Venous Thromboembolism After Total Hip Arthroplasty and Total Knee Arthroplasty: Current and Future Perspectives
Geno Merli, MD, FACP, FHM, FSVM
Advertisement
Advertisement